(Q72863715)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6251513%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

6-keto-prostaglandin E1 is not equipotent to prostacyclin (PGI2) as an antiaggregatory agent (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6251513%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

6-Keto-prostaglandin E1 is not equipotent to prostacyclin (PGI2) as an antiaggregatory agent (English)

1 reference

https://api.crossref.org/works/10.1016/S0090-6980(80)80056-6

7 September 2023

1 reference

https://api.crossref.org/works/10.1016/S0090-6980(80)80056-6

7 September 2023

1 reference

https://api.crossref.org/works/10.1016/S0090-6980(80)80056-6

7 September 2023

author name string

O. V. Miller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6251513

7 September 2023

J. W. Aiken

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6251513

7 September 2023

R. J. Shebuski

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6251513

7 September 2023

R. R. Gorman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6251513

7 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6251513

7 September 2023

publication date

1 August 1980

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6251513%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

29 October 2019

https://api.elsevier.com/content/article/PII:S0090698080800566?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0090-6980(80)80056-6

https://api.elsevier.com/content/article/PII:S0090698080800566?httpAccept=text/plain

7 September 2023

1 reference

https://api.crossref.org/works/10.1016/S0090-6980(80)80056-6

7 September 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6251513%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6251513%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6251513%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

391-400

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6251513%20AND%20SRC:MED&resulttype=core&format=json

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

29 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2880%2980056-6

7 January 2021

Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2880%2980056-6

7 January 2021

Modulation of human platelet adenylate cyclase by prostacyclin (PGX)

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2880%2980056-6

7 January 2021

Effects of prostacyclin (PGX) on cyclic AMP concentrations in human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2880%2980056-6

7 January 2021

6-Keto-prostaglandin E1 inhibits the aggregation of human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2880%2980056-6

7 January 2021

Platelet aggregation in partially obstructed vessels and its elimination with aspirin.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2880%2980056-6

7 January 2021

Prevention of blockage of partially obstructed coronary arteries with prostacyclin correlates with inhibition of platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2880%2980056-6

7 January 2021

Reversal of platelet aggregation by prostacyclin

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2880%2980056-6

7 January 2021

Hypotensive and renovascular actions of 6-keto-prostaglandin E1, a metabolite of prostacyclin

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2880%2980056-6

7 January 2021

Prostaglandin D2 inhibits the aggregation of human platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2880%2980056-6

7 January 2021

Stimulation of human platelet adenylate cyclase by prostaglandin D2

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2880%2980056-6

7 January 2021

Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2

10

1 reference

https://api.crossref.org/works/10.1016/S0090-6980(80)80056-6

Evidence for distinct prostaglandin I2 and D2 receptors in human platelets

7 September 2023

18

1 reference

https://api.crossref.org/works/10.1016/S0090-6980(80)80056-6

Prostacyclin analogs: antiaggregatory potency and enhancement of cAMP levels in human platelet rich plasma

7 September 2023

19

1 reference

https://api.crossref.org/works/10.1016/S0090-6980(80)80056-6

7 September 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6251513%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference